Home/Filings/4/0001415889-25-001062
4//SEC Filing

Bazemore Todd 4

Accession 0001415889-25-001062

CIK 0001479419other

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 8:14 PM ET

Size

10.9 KB

Accession

0001415889-25-001062

Insider Transaction Report

Form 4
Period: 2025-01-06
Bazemore Todd
SEE REMARKS
Transactions
  • Award

    Stock Option (right to buy)

    2025-01-06+45,20045,200 total
    Exercise: $7.53Exp: 2035-01-05Common Stock (45,200 underlying)
  • Award

    Common Stock

    2025-01-06+10,100
  • Sale

    Common Stock

    2025-01-06$7.63/sh1,993$15,207
Holdings
  • Common Stock

    (indirect: By son)
    1
Footnotes (5)
  • [F1]Grant of restricted stock units ("RSUs") under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the Reporting Person's continued employment with the Issuer, the RSUs will vest as to 1/3 of the shares underlying the RSUs on January 6, 2026, as to 1/3 of the shares underlying the RSUs on January 6, 2027 and as to the final 1/3 of shares underlying the RSUs on January 6, 2028.
  • [F2]Includes 64,324 unvested RSUs.
  • [F3]This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's RSUs granted on January 4, 2023 and January 4, 2024.
  • [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.48 to $7.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
  • [F5]This option was granted on January 6, 2025 and vests over four years beginning on the vesting commencement date of January 6, 2025, with 1/48th the shares underlying the option vesting at the end of each successive one-month period thereafter until January 6, 2029, subject to the Reporting Person's continued employment with the Issuer.

Issuer

KALA BIO, Inc.

CIK 0001479419

Entity typeother

Related Parties

1
  • filerCIK 0001605767

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 8:14 PM ET
Size
10.9 KB